Reply to letter on Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study

被引:6
|
作者
Beltran-Corbellini, A. [1 ]
Chico-Garcia, J. L. [1 ]
Martinez-Poles, J. [2 ,3 ]
Rodriguez-Jorge, F. [1 ]
Alonso-Canovas, A. [1 ]
机构
[1] Univ Hosp Ramon y Cajal, Dept Neurol, Madrid, Spain
[2] Hosp La Luz, Dept Neurol, Madrid, Spain
[3] Univ Hosp Clin San Carlos, Inst Sanit & Biomed Res Clin San Carlos IdISSC, Neurol Disorders Study Grp, Madrid, Spain
关键词
case–control study; coronavirus infection; PCR; smell disorders; taste disorders;
D O I
10.1111/ene.14359
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Specific respiratory tract infections, including COVID-19, may cause smell and/or taste disorders (STDs) with increased frequency. The aim was to determine whether new-onset STDs are more frequent amongst COVID-19 patients than influenza patients. Method: This was a case–control study including hospitalized patients of two tertiary care centres. Consecutive patients positive for COVID-19 polymerase chain reaction (cases) and patients positive for influenza polymerase chain reaction (historical control sample) were assessed during specific periods, employing a self-reported STD questionnaire. Results: Seventy-nine cases and 40 controls were included. No significant differences were found in basal features between the two groups. New-onset STDs were significantly more frequent amongst cases (31, 39.2%) than in the control group (5, 12.5 %) [adjusted odds ratio 21.4 (2.77–165.4, P = 0.003)]. COVID-19 patients with new-onset STDs were significantly younger than COVID-19 patients without STDs (52.6 ± 17.2 vs. 67.4 ± 15.1, P < 0.001). Amongst COVID-19 patients who presented STDs, 22 (70.9%) recalled an acute onset and it was an initial manifestation in 11 (35.5%). Twenty-five (80.6%) presented smell disorders (mostly anosmia, 14, 45.2%) and 28 (90.3%) taste disorders (mostly ageusia, 14, 45.2%). Only four (12.9 %) reported concomitant nasal obstruction. The mean duration of STD was 7.5 ± 3.2 days and 12 patients (40%) manifested complete recovery after 7.4 ± 2.3 days of onset. Conclusion: New-onset STDs were significantly more frequent amongst COVID-19 patients than influenza patients; they usually had an acute onset and were commonly an initial manifestation. The use of STD assessment in anamnesis as a hint for COVID-19 and to support individuals’ self-isolation in the current epidemic context is suggested. © 2020 European Academy of Neurology
引用
收藏
页码:E34 / E34
页数:1
相关论文
共 50 条
  • [21] The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control study
    Oz, Murat
    Meydanli, Mehmet Mutlu
    Altintas, Mufide Iclal
    Akilli, Huseyin
    Gultekin, Murat
    Ozgul, Nejat
    Salman, Mehmet Coskun
    Taskin, Salih
    Yaprak, Esra
    Taskiran, Cagatay
    Vatansever, Dogan
    Giray, Burak
    Yetkinel, Selcuk
    Celik, Husnu
    Onan, Mehmet Anil
    Ayhan, Ali
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 1286 - 1292
  • [22] Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study
    Kearns, Sean M.
    Ahern, Katelyn W.
    Patrie, James T.
    Horton, William B.
    Harris, Thurl E.
    Kadl, Alexandra
    PHYSIOLOGICAL REPORTS, 2021, 9 (07):
  • [23] Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study
    Ambrosino, Pasquale
    Calcaterra, Ilenia
    Molino, Antonio
    Moretta, Pasquale
    Lupoli, Roberta
    Spedicato, Giorgio Alfredo
    Papa, Antimo
    Motta, Andrea
    Maniscalco, Mauro
    Di Minno, Matteo Nicola Dario
    BIOMEDICINES, 2021, 9 (08)
  • [24] Acute kidney injury and mortality in patients with critical COVID-19 in Mexico: case-control study
    Mata-Maqueda, Ivette
    Solis-Sainz, Juan C.
    de Larrea, Guadalupe Zaldivar-Lelo
    Deloya-Tomas, Ernesto
    Lopez-Fermin, Jorge
    Olvera-Ramos, Ma Guadalupe
    Castillo-Gutierrez, Gabriela
    Carrion-Moya, Jorge D.
    Perez-Nieto, Orlando R.
    CIRUGIA Y CIRUJANOS, 2024, 92 (05): : 626 - 632
  • [25] Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
    Trigo, Javier
    Garcia-Azorin, David
    Sierra-Mencia, Alvaro
    Tamayo-Velasco, Alvaro
    Martinez-Paz, Pedro
    Tamayo, Eduardo
    Guerrero, Angel Luis
    Gonzalo-Benito, Hugo
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [26] Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
    Javier Trigo
    David García-Azorín
    Álvaro Sierra-Mencía
    Álvaro Tamayo-Velasco
    Pedro Martínez-Paz
    Eduardo Tamayo
    Angel Luis Guerrero
    Hugo Gonzalo-Benito
    The Journal of Headache and Pain, 2021, 22
  • [27] MRI findings in COVID-19 positive and COVID-19 negative patients presenting with acute neurological symptoms-a case-control study
    Mehta, Lakshay
    Gupta, R. K.
    Gupta, Praveen
    NEUROLOGY ASIA, 2022, 27 (01) : 117 - 123
  • [28] Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study
    Salvarani, C
    Farnetti, E
    Casali, B
    Nicoli, D
    Wenlan, L
    Bajocchi, G
    Macchioni, P
    Lo Scocco, G
    Catanoso, MG
    Boiardi, L
    Cantini, F
    ARTHRITIS AND RHEUMATISM, 2002, 46 (11): : 3099 - 3101
  • [29] Sleep Disorders in Patients with Parkinson's Disease during COVID-19 Pandemic: A Case-Control Study
    Desai, Ishita
    Gupta, Ravi
    Kumar, Mritunjai
    Tiwari, Ashutosh
    Kumar, Niraj
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (03) : 394 - 400
  • [30] Self-Rated Smell Ability Enables Highly Specific Predictors of COVID-19 Status: A Case-Control Study in Israel
    Karni, Noam
    Klein, Hadar
    Asseo, Kim
    Benjamini, Yuval
    Israel, Sarah
    Nammary, Musa
    Olshtain-Pops, Keren
    Nir-Paz, Ran
    Hershko, Alon
    Muszkat, Mordechai
    Niv, Masha Y.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):